FAIRFIELD, Conn., June 28, 2011 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) today announced that Forest Rehabilitation Medicine ("Forest") has begun treating patients with the Calmare® Pain Therapy medical device in its clinic on Staten Island. The Staten Island location and its Medical Director, Jack B. D'Angelo, M.D., MBA, are committed to developing new and challenging programs to enhance patient health and healthcare delivery.
Dr. Jack D'Angelo is widely recognized by the Staten Island community for his contributions for patient advocacy. "I have dedicated my many years of medical practice to helping patients manage and improve their condition," stated Dr. D'Angelo. "We have put the Calmare® through a rigorous clinical environment and it has satisfied our primary objective of improving the human condition. Forest has been officially approved as a Calmare® Certified location and our staff and myself are committed to providing Calmare® treatments to a large Staten Island community of chronic pain patients, especially patients suffering from chemotherapy-induced peripheral neuropathy, as well as other chronic neuropathic conditions."
"Competitive Technologies is pleased to add Forest Rehabilitation Medicine to our growing number of clinics throughout the United States," said Aris Despo, CTTC's Executive Vice President. "Dr. D'Angelo and his staff exhibit genuine care and concern for their patients and we are proud to announce that Forest is the first location to be designated Calmare® Certified under our new certification program. Their dedication to improving their patients' health and quality of life match our goal of bringing the Calmare® device and its underlying "Scrambler Therapy™" technology to more individuals who suffer from chronic neuropathic pain."
About Forest Rehabilitation Medicine, PC
Forest Rehabilitation Medicine, PC, is a comprehensive pain management clinic located in Staten Island, NY. Forest's Medical Director, Dr. Jack B. D'Angelo, MD is board certified in pediatrics and completed his physical medicine and MBA training at the George Washington University in Washington, DC.
As the first location to be certified under Competitive Technologies' new certification program, Forest's health care professionals have completed a comprehensive training regimen provided by CTTC's Calmare® Medical Specialist Trainers. Calmare® Certified treatment centers have satisfied specific certification requirements and demonstrate a continuing expertise with Calmare® Pain Therapy Treatment.
Forest Rehabilitation Medicine may be reached at 718.876.0203.
About Competitive Technologies, Inc
Competitive Technologies is a global leader in developing and commercializing innovative products and technologies. CTTC is multifaceted, providing distribution, patent and technology transfer, sales and licensing services. CTTC's staff is focused on the needs of customers and matching those requirements with commercially viable products or technology solutions.
CTTC is the licensed worldwide distributor of the non-invasive Calmare® pain therapy medical device, which incorporates the biophysical "Scrambler Therapy™" technology developed in Italy by CTTC's client, Professor Giuseppe Marineo to treat neuropathic pain, including cancer pain. The Calmare® device is currently being manufactured for sale by CTTC's partner, GEOMC Co., Ltd. of Seoul, Korea. For more information on the device, visit www.calmarett.com. Visit CTTC's website: www.competitivetech.net.
Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2010, filed with the SEC on October 27, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.